SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-009966
Filing Date
2017-08-29
Accepted
2017-08-28 21:06:14
Documents
5
Period of Report
2017-08-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31378
2 ex10-1.htm EX-10.1 17241
3 ex10-2.htm EX-10.2 9139
4 ex10-3.htm EX-10.3 8605
5 e10-2_001.jpg GRAPHIC 7201
  Complete submission text file 0001493152-17-009966.txt   77724
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 171055959
SIC: 2836 Biological Products, (No Diagnostic Substances)